Introduction: Active cancer and heart disease, which share similar environmental and biological characteristics,
can occur concomitantly. Open heart surgery may be required for these patients when indicated. This study aims
to demonstrate the early and long-term results and discuss the intervention strategy in patients with different types
of active malignancies, who underwent open-heart surgery.
Patients and Methods: Between January 2012 and May 2020, open-heart surgery was performed on 10
patients with active malignancies. The mean age was 65.5 (52-77), and four of the patients were female. Two
patients were operated on urgently due to advanced pleural effusion. AVR+CABG, CABG, CABG+left upper
lobectomy, and AVR+MVR were performed in four patients with lung cancer; AVR+CABG were performed
in one patient with colon cancer; CABG was performed in four patients each with one of the following conditions: lymphoma, breast cancer, essential thrombocytosis, meningioma); and mass resection operation from
the left atrium and left ventricle was performed in one patient with osteosarcoma.
Results: Eight patients were discharged and two patients died in the early postoperative period. Postoperative
left hemiparesis developed in one patient. Six-month, one-year and five-year survival rates were 79%, 37.5%
and 25%, respectively.
Conclusion: Open-heart surgery can be successfully performed with acceptable mortality and morbidity rates on
the high-risk patient group with active cancer.
Coronary artery bypass grafting cardiopulmonary bypass lung cancer breast cancer
Birincil Dil | İngilizce |
---|---|
Konular | Klinik Tıp Bilimleri |
Bölüm | Orijinal Araştırmalar |
Yazarlar | |
Yayımlanma Tarihi | 18 Nisan 2022 |
Yayımlandığı Sayı | Yıl 2022 Cilt: 25 Sayı: 1 |